ADP-ribosyltransferase PARP11 modulates the interferon antiviral response by mono-ADP-ribosylating the ubiquitin E3 ligase β-TrCP

T Guo, Y Zuo, L Qian, J Liu, Y Yuan, K Xu, Y Miao… - Nature …, 2019 - nature.com
Outbreaks of viral infections are a global health burden. Although type I interferon (IFN-I)
exerts broad-spectrum antiviral effects, its antiviral efficacy in host cells is largely restricted …

ADP-ribosyltransferase PARP11 modulates the interferon antiviral response by mono-ADP-ribosylating the ubiquitin E3 ligase β-TrCP

T Guo, Y Zuo, L Qian, J Liu, Y Yuan… - Nature …, 2019 - pubmed.ncbi.nlm.nih.gov
Outbreaks of viral infections are a global health burden. Although type I interferon (IFN-I)
exerts broad-spectrum antiviral effects, its antiviral efficacy in host cells is largely restricted …

ADP-ribosyltransferase PARP11 modulates the interferon antiviral response by mono-ADP-ribosylating the ubiquitin E3 ligase β-TrCP.

T Guo, Y Zuo, L Qian, J Liu, Y Yuan, K Xu… - Nature …, 2019 - europepmc.org
Outbreaks of viral infections are a global health burden. Although type I interferon (IFN-I)
exerts broad-spectrum antiviral effects, its antiviral efficacy in host cells is largely restricted …

ADP-ribosyltransferase PARP11 modulates the interferon antiviral response by mono-ADP-ribosylating the ubiquitin E3 ligase β-TrCP

G Tingting, Z Yibo, Q Liping, J Liu… - Nature …, 2019 - search.proquest.com
Outbreaks of viral infections are a global health burden. Although type I interferon (IFN-I)
exerts broad-spectrum antiviral effects, its antiviral efficacy in host cells is largely restricted …